Arthritis Leukopak

About Arthritis Leukopak

Arthritis Leukopak for Rheumatology and Immunology Research

LeukoCore Arthritis Human Leukopak biospecimens are collected by IRB-approved apheresis from donors with a clinically confirmed arthritis diagnosis, processed and shipped within 24 hours of collection. Each leukopak yields large quantities of peripheral blood mononuclear cells for immune profiling, cell isolation, and drug discovery. Every donor’s specific diagnosis is annotated, because “arthritis” is not one disease.

Which Type of Arthritis Do You Need?

Arthritis is a family of mechanistically distinct conditions that happen to share a joint as their target. Peripheral immune cells from these cohorts are not interchangeable, and this page deliberately does not claim a single mechanism. Choose the specific cohort that matches your target biology:

• Rheumatoid arthritis — a systemic autoimmune disease with rheumatoid factor and anti-citrullinated protein antibodies, and TNF/IL-6-driven synovitis
• Psoriatic arthritis — a seronegative, immune-mediated spondyloarthropathy running on a distinct IL-17/IL-23 axis
• Axial spondyloarthritis — HLA-B27-associated axial and entheseal inflammation, also IL-17/IL-23 dependent; see also ankylosing spondylitis cohorts
• Osteoarthritis — degenerative rather than autoimmune: cartilage matrix breakdown, subchondral bone remodelling, and osteophyte formation with only low-grade inflammation
• Gout — crystal-induced inflammation, with monosodium urate crystals activating the NLRP3 inflammasome and IL-1β release
• Systemic lupus erythematosus — immune-complex and interferon-driven disease with articular involvement

If your protocol calls for a broad arthritis cohort rather than a single diagnosis — for example method development, where you want the full analyte or phenotype range rather than one disease — we can assemble a mixed set with each donor’s specific diagnosis annotated. Cohort composition is the stratification axis on this page.

Cohort Composition and Donor Stratification

• Single-diagnosis cohort or defined mixed-arthritis cohort, built to your specification
• Seropositive versus seronegative disease, where serology has been performed
• Disease activity: active disease versus clinical remission
• Treatment status: treatment-naive, conventional DMARDs, biologics, or targeted synthetic DMARDs
• Disease duration, affected joints, and prior joint surgery
• Age, sex assigned at birth, race/ethnicity, and BMI
• Matched healthy controls available

Product Features

• Research Use Only (RUO) human arthritis leukopaks
• Clinically confirmed arthritis donors, with specific diagnosis annotated
• High cell yield for large-scale studies
• Processed and shipped within 24 hours of collection
• Fresh or cryopreserved options available
• IRB-approved and ethically sourced
• Infectious disease testing
• HLA-A typing
• Screen donors with LeukoLot™

De-identified Donor Data

• Verified arthritis diagnosis from healthcare providers, including subtype
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported medication history and allergies
• Relevant clinical data including arthritis severity and affected joints (if available)

Applications

• Comparative immunophenotyping across arthritis subtypes
• Isolation of T-cell, B-cell, monocyte, and NK subsets for functional assays
• Cytokine profiling and stimulation assays, including TNF, IL-6, IL-17, and IL-1β pathways
• NLRP3 inflammasome and crystal-induced inflammation research using gout cohorts
• Differential-diagnosis assay and classifier development across mechanistically distinct cohorts
• Biologic and JAK inhibitor mechanism-of-action and response studies
• Single-cell sequencing and multi-omic profiling
• Drug screening and target validation in patient-derived cells

Other Arthritis Specimen Types

• Arthritis PBMC — cryopreserved, for smaller-scale cellular work
• Arthritis Whole Blood — fresh, for same-day assays
• Arthritis Serum, Plasma, and Bulk Plasma — for soluble analytes
• Arthritis Synovial Fluid — the affected compartment itself, collected by arthrocentesis
• Pre-isolated subsets: CD4+ T cells, CD8+ T cells, CD19+ B cells, and CD56+ NK cells

Compliance and Quality Assurance

• Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
• HIPAA-compliant handling of donor information
• Rigorous donor screening and documentation

Ordering & Customization

Arthritis Human Leukopak samples are available fresh or cryopreserved. Need a different condition, or want to check current availability across our full leukopak inventory? Visit our human leukopak page to browse other disease-state options and live stock status. For pricing, international shipping, or regulatory documentation, please contact learnmore@sanguinebio.com to confirm regional compliance and shipping availability.